|
INTS6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.46170000945045E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.17929999099431E-09 |
| Normal-vs-Stage2 |
3.608700E-04 |
| Normal-vs-Stage3 |
3.009900E-04 |
| Normal-vs-Stage4 |
6.620900E-04 |
| Stage1-vs-Stage2 |
4.101800E-01 |
| Stage1-vs-Stage3 |
1.973830E-01 |
| Stage1-vs-Stage4 |
8.671800E-01 |
| Stage2-vs-Stage3 |
8.053200E-01 |
| Stage2-vs-Stage4 |
6.891600E-01 |
| Stage3-vs-Stage4 |
5.381800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29310004318251E-09 |
| Normal-vs-AfricanAmerican |
1.62435999999655E-05 |
| Normal-vs-Asian |
5.781300E-03 |
| Caucasian-vs-AfricanAmerican |
4.119600E-01 |
| Caucasian-vs-Asian |
9.937400E-01 |
| AfricanAmerican-vs-Asian |
7.778400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.37259126076606E-12 |
| Normal-vs-Female |
2.482300E-03 |
| Male-vs-Female |
1.015680E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.15529999994624E-06 |
| Normal-vs-Extreme_Weight |
3.01400016056164E-10 |
| Normal-vs-Obese |
7.57979999987946E-07 |
| Normal-vs-Extreme_Obese |
3.784700E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.042400E-01 |
| Normal_Weight-vs-Obese |
6.415800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.227400E-01 |
| Extreme_Weight-vs-Obese |
4.279700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.159000E-01 |
| Obese-vs-Extreme_Obese |
4.872600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.17719999999955E-05 |
| Normal-vs-Age(41-60Yrs) |
1.15830000002592E-06 |
| Normal-vs-Age(61-80Yrs) |
1.83110004936538E-09 |
| Normal-vs-Age(81-100Yrs) |
1.70875999999653E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.949800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.482200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.035000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.660300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.276780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.539200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.15347789284715E-12 |
| Normal-VS-Type2 PRCC |
4.12040000008496E-07 |
| Normal-VS-KIRP CIMP |
1.56653999999756E-05 |
| Normal-VS-Unclassified PRCC |
1.521510E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.801800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.767000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.059900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.939800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.261600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.994850E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.88959958791202E-10 |
| Normal-vs-N1 |
1.200350E-02 |
| Normal-vs-N2 |
1.278530E-03 |
| N0-vs-N1 |
2.933500E-02 |
| N0-vs-N2 |
3.268600E-01 |
| N1-vs-N2 |
2.837100E-03 |
|
|
